Cost-Effectiveness Analysis of Screening Chronic Kidney Disease in Iran
Introduction: The prevalence of Chronic Kidney Disease (CKD) in Iran amounts to 15.14%, which is higher than the global average. Given the substantial cost of this disease, health insurance companies need evidence of the cost-effectiveness of screening for the disease in adults at risk so that they...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2019-11-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/13295/42446_CE[Ra1]_F(KM)_PF1(AG_SHU)_PFA(SHU)_PB(AG_SHU)_PN(SL).pdf |